Systemic Sclerosis and Risk of Cardiovascular Disease: A PRISMA-compliant Systemic Review and Meta-analysis of Cohort Studies

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 Nov 21

PMID 33217802

Citations 8

Authors

Xintao Cen

Sining Feng

Shanshan Wei

Lu Yan

Ledong Sun

Affiliations

Soon will be listed here.

Abstract

Background: Systemic sclerosis (SSc) is an autoimmune disorder leading to extensive fibrosis and microvascular injury. Macrovascular disease is well documented in other autoimmune rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the link is unclear between SSc and macrovascular disease, particularly atherosclerotic cardiovascular disease (CVD). This meta-analysis aimed to investigate the association between SSc and CVD.

Methods: A thorough literature search was conducted in the Cochrane, Embase, Medline, and PubMed to identify all cohort studies comparing the risk of CVD with and without SSc. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) of cardiovascular end points were calculated. The risk of bias of included studies was assessed by the Newcastle-Ottawa scale.

Results: Seven cohort studies with a total of 14,813 study participants were included. In a comparison of SSc patients versus non-SSc controls, the pooled HR for cardiovascular disease was 2.36 (95% CI 1.97-2.81); for peripheral vascular disease was 5.27 (95%CI 4.27-6.51); for myocardial infarction was 2.36 (95% CI 1.71-3.25); and for stroke was 1.52 (95% CI 1.18-1.96).

Conclusion: This meta-analysis revealed that SSc was associated with an increased risk of CVD. Clinicians who manage patients with SSc should be aware of the increased cardiovascular burden and undertake preventive measures.

Citing Articles

Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.

Biscetti F, Polito G, Rando M, Nicolazzi M, Eraso L, DiMuzio P Int J Mol Sci. 2025; 26(2).

PMID: 39859250 PMC: 11765428. DOI: 10.3390/ijms26020535.

Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features.

Luo Y, Hanuska D, Xu J, Salvatore M, Bernstein E Semin Arthritis Rheum. 2024; 70():152598.

PMID: 39613484 PMC: 11710985. DOI: 10.1016/j.semarthrit.2024.152598.

Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease.

Heilmeier U, Feldmann D, Leynes A, Seng M, Jandova I, Keute M Front Med (Lausanne). 2024; 11:1446268.

PMID: 39564499 PMC: 11573558. DOI: 10.3389/fmed.2024.1446268.

Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis.

Benfaremo D, Pacenti N, Paterno I, Dichiara C, Galli F, Moroncini G J Scleroderma Relat Disord. 2024; 9(2):143-153.

PMID: 38910598 PMC: 11188851. DOI: 10.1177/23971983231224522.

Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis.

Chen I, Wang W, Lai Y, Lin C, Liu P, Wu S Sci Rep. 2024; 14(1):6445.

PMID: 38499699 PMC: 10948904. DOI: 10.1038/s41598-024-57275-9.

References

Schiopu E, Au K, McMahon M, Kaplan M, Divekar A, Singh R . Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford). 2013; 53(4):704-13. PMC: 4042927. DOI: 10.1093/rheumatology/ket411. View

Jordan S, Maurer B, Toniolo M, Michel B, Distler O . Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology (Oxford). 2015; 54(8):1454-8. DOI: 10.1093/rheumatology/keu530. View

Hesselvig J, Ahlehoff O, Dreyer L, Gislason G, Kofoed K . Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Lupus. 2016; 26(1):48-53. DOI: 10.1177/0961203316651739. View

Chu S, Chen Y, Liu C, Tseng W, Lin M, Hwang C . Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med. 2013; 126(11):982-8. DOI: 10.1016/j.amjmed.2013.06.025. View

Servettaz A, Guilpain P, Goulvestre C, Chereau C, Hercend C, Nicco C . Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis. 2007; 66(9):1202-9. PMC: 1955145. DOI: 10.1136/ard.2006.067504. View

Zoller B, Li X, Sundquist J, Sundquist K . Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012; 12:41. PMC: 3430565. DOI: 10.1186/1471-2377-12-41. View

Follansbee W, Curtiss E, Medsger Jr T, Steen V, Uretsky B, Owens G . Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984; 310(3):142-8. DOI: 10.1056/NEJM198401193100302. View

Silver R, Bogatkevich G, Tourkina E, Nietert P, Hoffman S . Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol. 2012; 24(6):642-8. PMC: 3756312. DOI: 10.1097/BOR.0b013e328356d9dc. View

Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P . Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol. 2014; 33(8):1099-104. DOI: 10.1007/s10067-014-2681-4. View

10.

Nikpour M, Stevens W, Herrick A, Proudman S . Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol. 2011; 24(6):857-69. DOI: 10.1016/j.berh.2010.10.007. View

11.

Man A, Zhu Y, Zhang Y, Dubreuil M, Rho Y, Peloquin C . The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis. 2012; 72(7):1188-93. PMC: 4386728. DOI: 10.1136/annrheumdis-2012-202007. View

12.

Sanjadi M, Rezvanie Sichanie Z, Totonchi H, Karami J, Rezaei R, Aslani S . Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis. 2018; 21(5):908-921. DOI: 10.1111/1756-185X.13309. View

13.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View

14.

Baraut J, Michel L, Verrecchia F, Farge D . Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev. 2010; 10(2):65-73. DOI: 10.1016/j.autrev.2010.08.003. View

15.

Mok M, Lau C, Chiu S, Tso A, Lo Y, Law L . Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis Rheum. 2011; 63(5):1387-95. DOI: 10.1002/art.30283. View

16.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

17.

Avina-Zubieta J, Man A, Yurkovich M, Huang K, Sayre E, Choi H . Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis. Am J Med. 2015; 129(3):324-31. DOI: 10.1016/j.amjmed.2015.10.037. View

18.

Frech T, Walker A, Barrett-OKeefe Z, Hopkins P, Richardson R, Wray D . Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction. Clin Rheumatol. 2014; 34(5):905-13. PMC: 4757465. DOI: 10.1007/s10067-014-2834-5. View

19.

Solomon D, Karlson E, Rimm E, Cannuscio C, Mandl L, Manson J . Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003; 107(9):1303-7. DOI: 10.1161/01.cir.0000054612.26458.b2. View

20.

Svegliati S, Spadoni T, Moroncini G, Gabrielli A . NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis. Free Radic Biol Med. 2018; 125:90-97. DOI: 10.1016/j.freeradbiomed.2018.04.554. View